Introduction

Reducing immune response damage in SCI with therapeutic stem cells

Reducing immune response damage in SCI with therapeutic stem cells

Researchers from Case Western Reserve University found that the immune system of spinal cord injury patients can be controlled using a family of therapeutic stem cells known as multipotent adult progenitor cells (MAPC),

The MAPCs have the ability to mediate the aggressive nature of macrophages. Importantly, though, the MPAC cells were also able to clear debris and were less disruptive to the healthy tissue.

“There was this remarkable neuroprotection with the friendlier macrophages,” research leader Jerry Silver, PhD, said in a press release,  “The spinal cord was just bigger, healthier, with much less tissue damage.”

Read more…  | Published paper